Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria

Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria

Nature Communications 8 Article number:14193 (2017); Published 31 January 2017; Updated 6 Apr 2017 This Article contains errors in Figs. 1 and 8 that were introduced during the production process. The compound on the lower right side of Fig. 1 is labelled incorrectly and should be labelled ‘SC83288’...

Full description

Bibliographic Details
Main Authors: Stefano Pegoraro, Maëlle Duffey, Thomas D. Otto, Yulin Wang, Roman Rösemann, Roland Baumgartner, Stefanie K. Fehler, Leonardo Lucantoni, Vicky M. Avery, Alicia Moreno-Sabater, Dominique Mazier, Henri J. Vial, Stefan Strobl, Cecilia P. Sanchez, Michael Lanzer
Format: Article
Language:English
Published: Nature Publishing Group 2017-04-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/ncomms15273
id doaj-65a3e0ea84b44bb1b074722eba24c8d6
record_format Article
spelling doaj-65a3e0ea84b44bb1b074722eba24c8d62021-05-11T07:02:14ZengNature Publishing GroupNature Communications2041-17232017-04-01811210.1038/ncomms15273Erratum: SC83288 is a clinical development candidate for the treatment of severe malariaStefano PegoraroMaëlle DuffeyThomas D. OttoYulin WangRoman RösemannRoland BaumgartnerStefanie K. FehlerLeonardo LucantoniVicky M. AveryAlicia Moreno-SabaterDominique MazierHenri J. VialStefan StroblCecilia P. SanchezMichael LanzerNature Communications 8 Article number:14193 (2017); Published 31 January 2017; Updated 6 Apr 2017 This Article contains errors in Figs. 1 and 8 that were introduced during the production process. The compound on the lower right side of Fig. 1 is labelled incorrectly and should be labelled ‘SC83288’. The correct version of Fig.https://doi.org/10.1038/ncomms15273
collection DOAJ
language English
format Article
sources DOAJ
author Stefano Pegoraro
Maëlle Duffey
Thomas D. Otto
Yulin Wang
Roman Rösemann
Roland Baumgartner
Stefanie K. Fehler
Leonardo Lucantoni
Vicky M. Avery
Alicia Moreno-Sabater
Dominique Mazier
Henri J. Vial
Stefan Strobl
Cecilia P. Sanchez
Michael Lanzer
spellingShingle Stefano Pegoraro
Maëlle Duffey
Thomas D. Otto
Yulin Wang
Roman Rösemann
Roland Baumgartner
Stefanie K. Fehler
Leonardo Lucantoni
Vicky M. Avery
Alicia Moreno-Sabater
Dominique Mazier
Henri J. Vial
Stefan Strobl
Cecilia P. Sanchez
Michael Lanzer
Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria
Nature Communications
author_facet Stefano Pegoraro
Maëlle Duffey
Thomas D. Otto
Yulin Wang
Roman Rösemann
Roland Baumgartner
Stefanie K. Fehler
Leonardo Lucantoni
Vicky M. Avery
Alicia Moreno-Sabater
Dominique Mazier
Henri J. Vial
Stefan Strobl
Cecilia P. Sanchez
Michael Lanzer
author_sort Stefano Pegoraro
title Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria
title_short Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria
title_full Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria
title_fullStr Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria
title_full_unstemmed Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria
title_sort erratum: sc83288 is a clinical development candidate for the treatment of severe malaria
publisher Nature Publishing Group
series Nature Communications
issn 2041-1723
publishDate 2017-04-01
description Nature Communications 8 Article number:14193 (2017); Published 31 January 2017; Updated 6 Apr 2017 This Article contains errors in Figs. 1 and 8 that were introduced during the production process. The compound on the lower right side of Fig. 1 is labelled incorrectly and should be labelled ‘SC83288’. The correct version of Fig.
url https://doi.org/10.1038/ncomms15273
work_keys_str_mv AT stefanopegoraro erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria
AT maelleduffey erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria
AT thomasdotto erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria
AT yulinwang erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria
AT romanrosemann erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria
AT rolandbaumgartner erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria
AT stefaniekfehler erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria
AT leonardolucantoni erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria
AT vickymavery erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria
AT aliciamorenosabater erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria
AT dominiquemazier erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria
AT henrijvial erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria
AT stefanstrobl erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria
AT ceciliapsanchez erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria
AT michaellanzer erratumsc83288isaclinicaldevelopmentcandidateforthetreatmentofseveremalaria
_version_ 1721452913274912768

Similar Items